Show simple item record

dc.contributor.authorWhite, Bethany Perez
dc.contributor.authorMolloy, Mary Ellen
dc.contributor.authorZhao, Huiping
dc.contributor.authorZhang, Yiyun
dc.contributor.authorTonetti, Debra A.
dc.date.accessioned2014-03-18T02:02:47Z
dc.date.available2014-03-18T02:02:47Z
dc.date.issued2013-05
dc.identifier.bibliographicCitationWhite, B. P., Molloy, M. E., Zhao, H. P., Zhang, Y. Y. and Tonetti, D. A. Extranuclear ER alpha is associated with regression of T47D PKC alpha-overexpressing, tamoxifen-resistant breast cancer. Molecular Cancer. 2013. 12. DOI: 10.1186/1476-4598-12-34en_US
dc.identifier.issn1476-4598
dc.identifier.urihttp://hdl.handle.net/10027/12820
dc.description© 2013 Perez White et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This is a copy of an article published in the Molecular Cancer © 2013 BioMed Centralen_US
dc.description.abstractBackground: Prior to the introduction of tamoxifen, high dose estradiol was used to treat breast cancer patients with similar efficacy as tamoxifen, albeit with some undesirable side effects. There is renewed interest to utilize estradiol to treat endocrine resistant breast cancers, especially since findings from several preclinical models and clinical trials indicate that estradiol may be a rational second-line therapy in patients exhibiting resistance to tamoxifen and/or aromatase inhibitors. We and others reported that breast cancer patients bearing protein kinase C alpha (PKC alpha)-expressing tumors exhibit endocrine resistance and tumor aggressiveness. Our T47D:A18/PKC alpha preclinical model is tamoxifen-resistant, hormone-independent, yet is inhibited by 17 beta-estradiol (E2) in vivo. We previously reported that E2-induced T47D:A18/PKC alpha tumor regression requires extranuclear ER alpha and interaction with the extracellular matrix. Methods: T47D:A18/PKC alpha cells were grown in vitro using two-dimensional (2D) cell culture, three-dimensional (3D) Matrigel and in vivo by establishing xenografts in athymic mice. Immunofluoresence confocal microscopy and co-localization were applied to determine estrogen receptor alpha (ER alpha) subcellular localization. Co-immunoprecipitation and western blot were used to examine interaction of ER alpha with caveolin-1. Results: We report that although T47D:A18/PKC alpha cells are cross-resistant to raloxifene in cell culture and in Matrigel, raloxifene induces regression of tamoxifen-resistant tumors. ER alpha rapidly translocates to extranuclear sites during T47D: A18/PKC alpha tumor regression in response to both raloxifene and E2, whereas ER alpha is primarily localized in the nucleus in proliferating tumors. E2 treatment induced complete tumor regression whereas cessation of raloxifene treatment resulted in tumor regrowth accompanied by re-localization of ER alpha to the nucleus. T47D:A18/neo tumors that do not overexpress PKC alpha maintain ER alpha in the nucleus during tamoxifen-mediated regression. An association between ER alpha and caveolin-1 increases in tumors regressing in response to E2. Conclusions: Extranuclear ER alpha plays a role in the regression of PKC alpha-overexpressing tamoxifen-resistant tumors. These studies underline the unique role of extranuclear ER alpha in E2- and raloxifene-induced tumor regression that may have implications for treatment of endocrine-resistant PKC alpha-expressing tumors encountered in the clinic.en_US
dc.description.sponsorshipNIH/NCI RO1 CA122914 (to DAT) and NIH/NIGMS T32 BM070388 (to BPW and MEM).en_US
dc.language.isoen_USen_US
dc.publisherBioMed Centralen_US
dc.subjectBreast canceren_US
dc.subjectPKCαen_US
dc.subjectExtranuclear ERαen_US
dc.titleExtranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast canceren_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record